| Hans-Günter Meyer-Thompson | International
EMCDDA. Maximising access to drug treatment while minimising diversion of medications — new EMCDDA report looks at striking the balance
EMCDDA. Maximising access to drug treatment while minimising diversion of medications — new EMCDDA report looks at striking the balance
Opioid substitution treatment (OST) is a key evidence-based tool used to manage opioid dependence and improve related health and social consequences. Yet increasing reports of the diversion and misuse of the controlled drugs used in this treatment in Europe are a cause for concern. In a new report out today, the EMCDDA highlights the various dimensions of the issue and the importance of balanced policies that maximise access to treatment while minimising diversion and misuse. (Lissabon, 11.02.2021)
https://www.emcdda.europa.eu/system/files/publications/13547/TD0121046ENN.pdf